about
Heparin-induced non-necrotizing skin lesions: rarely associated with heparin-induced thrombocytopenia.Non-necrotizing heparin-induced skin lesions and the 4T's score.[Dermal necrosis as cutaneous manifestation of heparin-induced thrombocytopenia II?].Low allergenic potential with fondaparinux: results of a prospective investigation.Heparin modifies the immunogenicity of positively charged proteins.Recent advances in the diagnosis and treatment of heparin-induced thrombocytopenia.An update on heparin-induced thrombocytopenia: diagnosis and management.Nadroparin carries a potentially high risk of inducing cutaneous delayed-type hypersensitivity responses.Effect of subcutaneous Enoxaparin injection duration on bruising size in acute coronary syndrome patients.The risk for cross-reactions after a cutaneous delayed-type hypersensitivity reaction to heparin preparations is independent of their molecular weight: a systematic review.Cutaneous adverse events associated with heparin.An eruption of angiokeratomas in the setting of enoxaparin injections.Heparin-induced haemorrhagic bullous dermatosis.Bivalirudin for prevention of prosthetic valve thrombosis in heparin allergy.Non-immediate heparin and heparinoid cutaneous allergic reactions: a role for fondaparinux.A GENS-based approach to cardiovascular pharmacology: impact on metabolism, pharmacokinetics and pharmacodynamics
P2860
Q33388098-4809D5B1-C7CA-4DE6-9A6F-21BE82F25561Q33389196-FFA9CC97-4FFE-40F0-9640-B622B45FDBACQ33391842-DA817AF1-C6EA-43E4-8179-13914EB1332FQ33391886-67CC6017-C5E7-4347-A05C-76540DD306BAQ33391937-820B0F91-1A28-416B-98E9-A250B992CFA1Q33407198-C5396BE0-023F-436B-8B26-82E36ECD31A2Q33430644-4508F898-B86C-4C8F-9FE6-E00A12979361Q33440138-F086DCFE-E860-4B13-BACD-DD49029D20E4Q34794068-51D14C3E-A9EE-4EA0-9C6D-CBA539300018Q37883468-61B13634-E8CE-497B-A5F2-0292335B631BQ38045445-5D20E6DD-68FB-4CF5-9A0C-CB20E2EB1DEEQ45294797-5403E5B6-D43C-4235-B83C-009A1CE119ADQ47240712-505E8B5B-A0F9-4BD8-AD78-002454DEF2CDQ47875463-DB82F4BE-4BC1-41F6-BE25-72C304F9AD14Q48286529-BEF07D60-8FBD-41C2-B57F-D0851AF62CB4Q58294605-0FD6DCEC-B6DE-4F49-BC65-F31894596DC6
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Incidence and causes of heparin-induced skin lesions
@ast
Incidence and causes of heparin-induced skin lesions
@en
type
label
Incidence and causes of heparin-induced skin lesions
@ast
Incidence and causes of heparin-induced skin lesions
@en
prefLabel
Incidence and causes of heparin-induced skin lesions
@ast
Incidence and causes of heparin-induced skin lesions
@en
P2093
P2860
P356
P1476
Incidence and causes of heparin-induced skin lesions
@en
P2093
Andreas Recke
Edelgard Lindhoff-Last
Hartmut Kroll
Manfred Wolter
Marc Schindewolf
Roland Kaufmann
Svantje Schwaner
Wolf-Henning Boehncke
P2860
P304
P356
10.1503/CMAJ.081729
P407
P577
2009-09-28T00:00:00Z